Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid functioning during treatment for depression

M Kusalic1, F Engelsmann, J Bradwejn

  • 1Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

Journal of Psychiatry & Neuroscience : JPN
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of psychosomatic and other medical illnesses in anorexic and bulimic patients.

Behavioural neurology·2014
Same author

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

CNS drugs·2013
Same author

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

Depression and anxiety·2012
Same author

The cholecystokinin hypothesis of panic and anxiety disorders: a review.

Journal of psychopharmacology (Oxford, England)·2012
Same author

A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder.

Psychological medicine·2010
Same author

Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany.

Neuroscience letters·2004
Same journal

Dynamics of thoughts-novel candidate marker for differential-diagnosis of mental disorders?

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Differences in cortical gyrification and fractional amplitude of low-frequency fluctuations between early- and late-onset obsessive-compulsive disorder.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Major depressive disorder is associated with reduced intrinsic connectivity between the bed nucleus of the stria terminalis and ventral striatum.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

The Eph-ephrin system in neuropsychiatric and neurodevelopmental disorders.

Journal of psychiatry & neuroscience : JPN·2026
Same journal

Machine learning-based computational validation of the Addictions Neuroclinical Assessment framework in relation to hazardous drinking.

Journal of psychiatry & neuroscience : JPN·2026
See all related articles

This study found that amitriptyline significantly decreased thyroid hormone levels (T4 and fT4) in patients who responded to treatment for unipolar depression. Other treatments showed minimal non-significant changes in thyroid hormones and weight.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Psychiatry

Background:

  • Unipolar depression is a common mood disorder with complex pathophysiology.
  • Thyroid hormone levels have been implicated in mood regulation and depression.
  • Antidepressant medications can influence various physiological systems, including the endocrine system.

Purpose of the Study:

  • To investigate the effects of moclobemide, placebo, and amitriptyline on thyroid hormone levels in patients with unipolar depression.
  • To compare the impact of these treatments on thyroid hormones (T4 and fT4) in relation to treatment response and weight changes.

Main Methods:

  • A double-blind study involving 39 unipolar depressed patients.
  • Patients underwent a 7-day washout period before 42 days of treatment with moclobemide, placebo, or amitriptyline.

Related Experiment Videos

  • Psychopathological assessments (including Hamilton Rating Scale for Depression - HRSD) and thyroid analyses were conducted at regular intervals.

    • Main Results:

    • Amitriptyline treatment led to a significant decrease in T4 and fT4 levels in responders.
    • Moclobemide and placebo treatments resulted in non-significant changes in T4 and fT4 levels in responders.
    • Non-responders showed non-significant increases in T4 and fT4 values across all treatment groups.
    • Minimal and non-significant weight changes were observed in all groups.

    Conclusions:

    • Amitriptyline may influence thyroid hormone regulation in patients responding to depression treatment.
    • The observed thyroid hormone changes with amitriptyline do not appear to be linked to significant weight alterations.
    • Further research is needed to elucidate the clinical significance of these thyroid-related effects in antidepressant therapy.